Chile vs Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received the final dose of
Chile
87.0%
in 2024
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
44.0%
in 2024
Chile rank
16th
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank
17th
Proportion of the target population who received the final dose of over time
- Chile
- Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)
How they compare
Chile currently reports 87.0% against 44.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), a difference of 43.0%.
That makes Chile's figure about 2.0 times Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)'s.
Across all 10 years both countries report, Chile has been ahead every year.
Chile ranks 16th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 17th of 107 countries.
Chile has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.8% | 34.8% | 43.0% | Chile |
| 2020s | 74.6% | 41.4% | 33.2% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Chile or Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- Chile, at 87.0% against 44.0% in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Chile and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 43.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
- 10 years are reported by both, from 2015 to 2024.
- How do Chile and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank globally for proportion of the target population who received the final dose of?
- Chile ranks 16th and Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 17th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.